APO Research
Talk to an analyst

APO RESEARCH · REPORT

Steroidal MRAs

Compare research editions
View pricing & licenses

Selected research

Industry Research

Steroidal MRAs Industry Research Report 2026

28 December 2025149 pages

Choose your research edition.

Industry ResearchSteroidal MRAs Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Steroidal MRAs Industry Growth and Trends Forecast to 2032129 pages · $3,450 USDMarket StructureGlobal Steroidal MRAs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Steroidal MRAs Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Steroidal MRAs Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Steroidal MRAs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Steroidal MRAs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Steroidal MRAs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Steroidal MRAs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Steroidal MRAs include Chongqing Kerui Pharmaceutical, Jiangsu Chia Tai Fenghai Pharmaceutical, Grand Pharmaceutical, Yatai Pharma, Suzhou Homesun Pharmaceutical, Shanghai Xinyi Wanxiang pharmaceutical, Jiangsu Changjiang Pharmaceutical, Jiangsu Yunyang Pharmaceutical Group and Hangzhou Minsheng Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Steroidal MRAs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Steroidal MRAs Market by Company

Chongqing Kerui Pharmaceutical

Jiangsu Chia Tai Fenghai Pharmaceutical

Grand Pharmaceutical

Yatai Pharma

Suzhou Homesun Pharmaceutical

Shanghai Xinyi Wanxiang pharmaceutical

Jiangsu Changjiang Pharmaceutical

Jiangsu Yunyang Pharmaceutical Group

Hangzhou Minsheng Pharmaceutical

Sinopharm Zhonglian Pharmaceutical

Zydus

Viatris Pharmaceuticals

Sun Pharmaceuticals

Sandoz

Pfizer

Mylan

MSN

Kyorin Rimedio

Camber Pharmaceuticals

Amneal Pharmaceuticals

Actavis Elizabeth

Accord Healthcare

Steroidal MRAs Segment by Type

Spironolactone

Eplerenone

Steroidal MRAs Segment by Application

Hypertension

Aldosteronism

Edema

Heart failure

Others

Steroidal MRAs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Steroidal MRAs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Steroidal MRAs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Steroidal MRAs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Steroidal MRAs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Steroidal MRAs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Steroidal MRAs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Steroidal MRAs Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Steroidal MRAs Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Steroidal MRAs Sales Market Share by Manufacturers (2021-2026) Table 8. Global Steroidal MRAs Revenue of Manufacturers (2021-2026) Table 9. Global Steroidal MRAs Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Steroidal MRAs Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Steroidal MRAs Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Steroidal MRAs, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Steroidal MRAs, Product Type & Application Table 14. Global Steroidal MRAs Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Steroidal MRAs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Chongqing Kerui Pharmaceutical Company Information Table 19. Chongqing Kerui Pharmaceutical Business Overview Table 20. Chongqing Kerui Pharmaceutical Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Chongqing Kerui Pharmaceutical Steroidal MRAs Product Portfolio Table 22. Chongqing Kerui Pharmaceutical Recent Developments Table 23. Jiangsu Chia Tai Fenghai Pharmaceutical Company Information Table 24. Jiangsu Chia Tai Fenghai Pharmaceutical Business Overview Table 25. Jiangsu Chia Tai Fenghai Pharmaceutical Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Jiangsu Chia Tai Fenghai Pharmaceutical Steroidal MRAs Product Portfolio Table 27. Jiangsu Chia Tai Fenghai Pharmaceutical Recent Developments Table 28. Grand Pharmaceutical Company Information Table 29. Grand Pharmaceutical Business Overview Table 30. Grand Pharmaceutical Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Grand Pharmaceutical Steroidal MRAs Product Portfolio Table 32. Grand Pharmaceutical Recent Developments Table 33. Yatai Pharma Company Information Table 34. Yatai Pharma Business Overview Table 35. Yatai Pharma Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Yatai Pharma Steroidal MRAs Product Portfolio Table 37. Yatai Pharma Recent Developments Table 38. Suzhou Homesun Pharmaceutical Company Information Table 39. Suzhou Homesun Pharmaceutical Business Overview Table 40. Suzhou Homesun Pharmaceutical Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Suzhou Homesun Pharmaceutical Steroidal MRAs Product Portfolio Table 42. Suzhou Homesun Pharmaceutical Recent Developments Table 43. Shanghai Xinyi Wanxiang pharmaceutical Company Information Table 44. Shanghai Xinyi Wanxiang pharmaceutical Business Overview Table 45. Shanghai Xinyi Wanxiang pharmaceutical Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Shanghai Xinyi Wanxiang pharmaceutical Steroidal MRAs Product Portfolio Table 47. Shanghai Xinyi Wanxiang pharmaceutical Recent Developments Table 48. Jiangsu Changjiang Pharmaceutical Company Information Table 49. Jiangsu Changjiang Pharmaceutical Business Overview Table 50. Jiangsu Changjiang Pharmaceutical Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Jiangsu Changjiang Pharmaceutical Steroidal MRAs Product Portfolio Table 52. Jiangsu Changjiang Pharmaceutical Recent Developments Table 53. Jiangsu Yunyang Pharmaceutical Group Company Information Table 54. Jiangsu Yunyang Pharmaceutical Group Business Overview Table 55. Jiangsu Yunyang Pharmaceutical Group Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Jiangsu Yunyang Pharmaceutical Group Steroidal MRAs Product Portfolio Table 57. Jiangsu Yunyang Pharmaceutical Group Recent Developments Table 58. Hangzhou Minsheng Pharmaceutical Company Information Table 59. Hangzhou Minsheng Pharmaceutical Business Overview Table 60. Hangzhou Minsheng Pharmaceutical Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Hangzhou Minsheng Pharmaceutical Steroidal MRAs Product Portfolio Table 62. Hangzhou Minsheng Pharmaceutical Recent Developments Table 63. Sinopharm Zhonglian Pharmaceutical Company Information Table 64. Sinopharm Zhonglian Pharmaceutical Business Overview Table 65. Sinopharm Zhonglian Pharmaceutical Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Sinopharm Zhonglian Pharmaceutical Steroidal MRAs Product Portfolio Table 67. Sinopharm Zhonglian Pharmaceutical Recent Developments Table 68. Zydus Company Information Table 69. Zydus Business Overview Table 70. Zydus Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Zydus Steroidal MRAs Product Portfolio Table 72. Zydus Recent Developments Table 73. Viatris Pharmaceuticals Company Information Table 74. Viatris Pharmaceuticals Business Overview Table 75. Viatris Pharmaceuticals Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Viatris Pharmaceuticals Steroidal MRAs Product Portfolio Table 77. Viatris Pharmaceuticals Recent Developments Table 78. Sun Pharmaceuticals Company Information Table 79. Sun Pharmaceuticals Business Overview Table 80. Sun Pharmaceuticals Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Sun Pharmaceuticals Steroidal MRAs Product Portfolio Table 82. Sun Pharmaceuticals Recent Developments Table 83. Sandoz Company Information Table 84. Sandoz Business Overview Table 85. Sandoz Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Sandoz Steroidal MRAs Product Portfolio Table 87. Sandoz Recent Developments Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Pfizer Steroidal MRAs Product Portfolio Table 92. Pfizer Recent Developments Table 93. Mylan Company Information Table 94. Mylan Business Overview Table 95. Mylan Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Mylan Steroidal MRAs Product Portfolio Table 97. Mylan Recent Developments Table 98. MSN Company Information Table 99. MSN Business Overview Table 100. MSN Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. MSN Steroidal MRAs Product Portfolio Table 102. MSN Recent Developments Table 103. Kyorin Rimedio Company Information Table 104. Kyorin Rimedio Business Overview Table 105. Kyorin Rimedio Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Kyorin Rimedio Steroidal MRAs Product Portfolio Table 107. Kyorin Rimedio Recent Developments Table 108. Camber Pharmaceuticals Company Information Table 109. Camber Pharmaceuticals Business Overview Table 110. Camber Pharmaceuticals Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Camber Pharmaceuticals Steroidal MRAs Product Portfolio Table 112. Camber Pharmaceuticals Recent Developments Table 113. Amneal Pharmaceuticals Company Information Table 114. Amneal Pharmaceuticals Business Overview Table 115. Amneal Pharmaceuticals Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Amneal Pharmaceuticals Steroidal MRAs Product Portfolio Table 117. Amneal Pharmaceuticals Recent Developments Table 118. Actavis Elizabeth Company Information Table 119. Actavis Elizabeth Business Overview Table 120. Actavis Elizabeth Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Actavis Elizabeth Steroidal MRAs Product Portfolio Table 122. Actavis Elizabeth Recent Developments Table 123. Accord Healthcare Company Information Table 124. Accord Healthcare Business Overview Table 125. Accord Healthcare Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Accord Healthcare Steroidal MRAs Product Portfolio Table 127. Accord Healthcare Recent Developments Table 128. Global Steroidal MRAs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 129. Global Steroidal MRAs Sales by Region (2021-2026) & (K Units) Table 130. Global Steroidal MRAs Sales Market Share by Region (2021-2026) Table 131. Global Steroidal MRAs Sales by Region (2027-2032) & (K Units) Table 132. Global Steroidal MRAs Sales Market Share by Region (2027-2032) Table 133. Global Steroidal MRAs Revenue by Region (2021-2026) & (US$ Million) Table 134. Global Steroidal MRAs Revenue Market Share by Region (2021-2026) Table 135. Global Steroidal MRAs Revenue by Region (2027-2032) & (US$ Million) Table 136. Global Steroidal MRAs Revenue Market Share by Region (2027-2032) Table 137. North America Steroidal MRAs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. North America Steroidal MRAs Sales by Country (2021-2026) & (K Units) Table 139. North America Steroidal MRAs Sales by Country (2027-2032) & (K Units) Table 140. North America Steroidal MRAs Revenue by Country (2021-2026) & (US$ Million) Table 141. North America Steroidal MRAs Revenue by Country (2027-2032) & (US$ Million) Table 142. Europe Steroidal MRAs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Europe Steroidal MRAs Sales by Country (2021-2026) & (K Units) Table 144. Europe Steroidal MRAs Sales by Country (2027-2032) & (K Units) Table 145. Europe Steroidal MRAs Revenue by Country (2021-2026) & (US$ Million) Table 146. Europe Steroidal MRAs Revenue by Country (2027-2032) & (US$ Million) Table 147. Asia Pacific Steroidal MRAs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Asia Pacific Steroidal MRAs Sales by Country (2021-2026) & (K Units) Table 149. Asia Pacific Steroidal MRAs Sales by Country (2027-2032) & (K Units) Table 150. Asia Pacific Steroidal MRAs Revenue by Country (2021-2026) & (US$ Million) Table 151. Asia Pacific Steroidal MRAs Revenue by Country (2027-2032) & (US$ Million) Table 152. South America Steroidal MRAs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. South America Steroidal MRAs Sales by Country (2021-2026) & (K Units) Table 154. South America Steroidal MRAs Sales by Country (2027-2032) & (K Units) Table 155. South America Steroidal MRAs Revenue by Country (2021-2026) & (US$ Million) Table 156. South America Steroidal MRAs Revenue by Country (2027-2032) & (US$ Million) Table 157. Middle East and Africa Steroidal MRAs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. Middle East and Africa Steroidal MRAs Sales by Country (2021-2026) & (K Units) Table 159. Middle East and Africa Steroidal MRAs Sales by Country (2027-2032) & (K Units) Table 160. Middle East and Africa Steroidal MRAs Revenue by Country (2021-2026) & (US$ Million) Table 161. Middle East and Africa Steroidal MRAs Revenue by Country (2027-2032) & (US$ Million) Table 162. Global Steroidal MRAs Sales by Type (2021-2026) & (K Units) Table 163. Global Steroidal MRAs Sales by Type (2027-2032) & (K Units) Table 164. Global Steroidal MRAs Sales Market Share by Type (2021-2026) Table 165. Global Steroidal MRAs Sales Market Share by Type (2027-2032) Table 166. Global Steroidal MRAs Revenue by Type (2021-2026) & (US$ Million) Table 167. Global Steroidal MRAs Revenue by Type (2027-2032) & (US$ Million) Table 168. Global Steroidal MRAs Revenue Market Share by Type (2021-2026) Table 169. Global Steroidal MRAs Revenue Market Share by Type (2027-2032) Table 170. Global Steroidal MRAs Price by Type (2021-2026) & (US$/Unit) Table 171. Global Steroidal MRAs Price by Type (2027-2032) & (US$/Unit) Table 172. Global Steroidal MRAs Sales by Application (2021-2026) & (K Units) Table 173. Global Steroidal MRAs Sales by Application (2027-2032) & (K Units) Table 174. Global Steroidal MRAs Sales Market Share by Application (2021-2026) Table 175. Global Steroidal MRAs Sales Market Share by Application (2027-2032) Table 176. Global Steroidal MRAs Revenue by Application (2021-2026) & (US$ Million) Table 177. Global Steroidal MRAs Revenue by Application (2027-2032) & (US$ Million) Table 178. Global Steroidal MRAs Revenue Market Share by Application (2021-2026) Table 179. Global Steroidal MRAs Revenue Market Share by Application (2027-2032) Table 180. Global Steroidal MRAs Price by Application (2021-2026) & (US$/Unit) Table 181. Global Steroidal MRAs Price by Application (2027-2032) & (US$/Unit) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Steroidal MRAs Distributors List Table 185. Steroidal MRAs Customers List Table 186. Steroidal MRAs Industry Trends Table 187. Steroidal MRAs Industry Drivers Table 188. Steroidal MRAs Industry Restraints Table 189. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Steroidal MRAs Product Image Figure 5. Global Steroidal MRAs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Steroidal MRAs Market Size (2021-2032) & (US$ Million) Figure 7. Global Steroidal MRAs Sales (2021-2032) & (K Units) Figure 8. Global Steroidal MRAs Average Price (US$/Unit) & (2021-2032) Figure 9. Spironolactone Product Image Figure 10. Eplerenone Product Image Figure 11. Hypertension Product Image Figure 12. Aldosteronism Product Image Figure 13. Edema Product Image Figure 14. Heart failure Product Image Figure 15. Others Product Image Figure 16. Global Steroidal MRAs Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Steroidal MRAs, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Steroidal MRAs Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Steroidal MRAs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Steroidal MRAs Sales by Region in 2025 Figure 22. Global Steroidal MRAs Revenue by Region in 2025 Figure 23. North America Steroidal MRAs Market Size by Country in 2025 Figure 24. North America Steroidal MRAs Sales Market Share by Country (2021-2032) Figure 25. North America Steroidal MRAs Revenue Market Share by Country (2021-2032) Figure 26. United States Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Steroidal MRAs Market Size by Country in 2025 Figure 30. Europe Steroidal MRAs Sales Market Share by Country (2021-2032) Figure 31. Europe Steroidal MRAs Revenue Market Share by Country (2021-2032) Figure 32. Germany Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Steroidal MRAs Market Size by Country in 2025 Figure 43. Asia Pacific Steroidal MRAs Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Steroidal MRAs Revenue Market Share by Country (2021-2032) Figure 45. China Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Steroidal MRAs Market Size by Country in 2025 Figure 54. South America Steroidal MRAs Sales Market Share by Country (2021-2032) Figure 55. South America Steroidal MRAs Revenue Market Share by Country (2021-2032) Figure 56. Brazil Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Steroidal MRAs Market Size by Country in 2025 Figure 60. Middle East and Africa Steroidal MRAs Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Steroidal MRAs Revenue Market Share by Country (2021-2032) Figure 62. Egypt Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Steroidal MRAs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Steroidal MRAs Sales Market Share by Type (2021-2032) Figure 68. Global Steroidal MRAs Revenue Market Share by Type (2021-2032) Figure 69. Global Steroidal MRAs Price (US$/Unit) by Type (2021-2032) Figure 70. Global Steroidal MRAs Sales Market Share by Application (2021-2032) Figure 71. Global Steroidal MRAs Revenue Market Share by Application (2021-2032) Figure 72. Global Steroidal MRAs Price (US$/Unit) by Application (2021-2032) Figure 73. Steroidal MRAs Value Chain Figure 74. Steroidal MRAs Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Steroidal MRAs Industry Opportunities and Challenges

Scope & coverage.

Types
  • Spironolactone
  • Eplerenone
Applications
  • Hypertension
  • Aldosteronism
  • Edema
  • Heart failure
  • Others
Companies covered
  • Chongqing Kerui Pharmaceutical
  • Jiangsu Chia Tai Fenghai Pharmaceutical
  • Grand Pharmaceutical
  • Yatai Pharma
  • Suzhou Homesun Pharmaceutical
  • Shanghai Xinyi Wanxiang pharmaceutical
  • Jiangsu Changjiang Pharmaceutical
  • Jiangsu Yunyang Pharmaceutical Group
  • Hangzhou Minsheng Pharmaceutical
  • Sinopharm Zhonglian Pharmaceutical
  • Zydus
  • Viatris Pharmaceuticals
  • Sun Pharmaceuticals
  • Sandoz
  • Pfizer
  • Mylan
  • MSN
  • Kyorin Rimedio
  • Camber Pharmaceuticals
  • Amneal Pharmaceuticals
  • Actavis Elizabeth
  • Accord Healthcare

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Steroidal MRAs Market Size (2021-2032)
  4. 2.2.2 Global Steroidal MRAs Sales (2021-2032)
  5. 2.2.3 Global Steroidal MRAs Market Average Price (2021-2032)
  6. 2.3 Steroidal MRAs by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Spironolactone
  9. 2.3.3 Eplerenone
  10. 2.4 Steroidal MRAs by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hypertension
  13. 2.4.3 Aldosteronism
  14. 2.4.4 Edema
  15. 2.4.5 Heart failure
  16. 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Steroidal MRAs Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Steroidal MRAs Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Steroidal MRAs Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Steroidal MRAs Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Steroidal MRAs Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Steroidal MRAs, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Steroidal MRAs, Product Type & Application
  8. 3.8 Global Manufacturers of Steroidal MRAs, Established Date
  9. 3.9 Global Steroidal MRAs Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Chongqing Kerui Pharmaceutical
  2. 4.1.1 Chongqing Kerui Pharmaceutical Company Information
  3. 4.1.2 Chongqing Kerui Pharmaceutical Business Overview
  4. 4.1.3 Chongqing Kerui Pharmaceutical Steroidal MRAs Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Chongqing Kerui Pharmaceutical Steroidal MRAs Product Portfolio
  6. 4.1.5 Chongqing Kerui Pharmaceutical Recent Developments
  7. 4.2 Jiangsu Chia Tai Fenghai Pharmaceutical
  8. 4.2.1 Jiangsu Chia Tai Fenghai Pharmaceutical Company Information
  9. 4.2.2 Jiangsu Chia Tai Fenghai Pharmaceutical Business Overview
  10. 4.2.3 Jiangsu Chia Tai Fenghai Pharmaceutical Steroidal MRAs Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Jiangsu Chia Tai Fenghai Pharmaceutical Steroidal MRAs Product Portfolio
  12. 4.2.5 Jiangsu Chia Tai Fenghai Pharmaceutical Recent Developments
  13. 4.3 Grand Pharmaceutical
  14. 4.3.1 Grand Pharmaceutical Company Information
  15. 4.3.2 Grand Pharmaceutical Business Overview
  16. 4.3.3 Grand Pharmaceutical Steroidal MRAs Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Grand Pharmaceutical Steroidal MRAs Product Portfolio
  18. 4.3.5 Grand Pharmaceutical Recent Developments
  19. 4.4 Yatai Pharma
  20. 4.4.1 Yatai Pharma Company Information
  21. 4.4.2 Yatai Pharma Business Overview
  22. 4.4.3 Yatai Pharma Steroidal MRAs Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Yatai Pharma Steroidal MRAs Product Portfolio
  24. 4.4.5 Yatai Pharma Recent Developments
  25. 4.5 Suzhou Homesun Pharmaceutical
  26. 4.5.1 Suzhou Homesun Pharmaceutical Company Information
  27. 4.5.2 Suzhou Homesun Pharmaceutical Business Overview
  28. 4.5.3 Suzhou Homesun Pharmaceutical Steroidal MRAs Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Suzhou Homesun Pharmaceutical Steroidal MRAs Product Portfolio
  30. 4.5.5 Suzhou Homesun Pharmaceutical Recent Developments
  31. 4.6 Shanghai Xinyi Wanxiang pharmaceutical
  32. 4.6.1 Shanghai Xinyi Wanxiang pharmaceutical Company Information
  33. 4.6.2 Shanghai Xinyi Wanxiang pharmaceutical Business Overview
  34. 4.6.3 Shanghai Xinyi Wanxiang pharmaceutical Steroidal MRAs Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Shanghai Xinyi Wanxiang pharmaceutical Steroidal MRAs Product Portfolio
  36. 4.6.5 Shanghai Xinyi Wanxiang pharmaceutical Recent Developments
  37. 4.7 Jiangsu Changjiang Pharmaceutical
  38. 4.7.1 Jiangsu Changjiang Pharmaceutical Company Information
  39. 4.7.2 Jiangsu Changjiang Pharmaceutical Business Overview
  40. 4.7.3 Jiangsu Changjiang Pharmaceutical Steroidal MRAs Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Jiangsu Changjiang Pharmaceutical Steroidal MRAs Product Portfolio
  42. 4.7.5 Jiangsu Changjiang Pharmaceutical Recent Developments
  43. 4.8 Jiangsu Yunyang Pharmaceutical Group
  44. 4.8.1 Jiangsu Yunyang Pharmaceutical Group Company Information
  45. 4.8.2 Jiangsu Yunyang Pharmaceutical Group Business Overview
  46. 4.8.3 Jiangsu Yunyang Pharmaceutical Group Steroidal MRAs Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Jiangsu Yunyang Pharmaceutical Group Steroidal MRAs Product Portfolio
  48. 4.8.5 Jiangsu Yunyang Pharmaceutical Group Recent Developments
  49. 4.9 Hangzhou Minsheng Pharmaceutical
  50. 4.9.1 Hangzhou Minsheng Pharmaceutical Company Information
  51. 4.9.2 Hangzhou Minsheng Pharmaceutical Business Overview
  52. 4.9.3 Hangzhou Minsheng Pharmaceutical Steroidal MRAs Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Hangzhou Minsheng Pharmaceutical Steroidal MRAs Product Portfolio
  54. 4.9.5 Hangzhou Minsheng Pharmaceutical Recent Developments
  55. 4.10 Sinopharm Zhonglian Pharmaceutical
  56. 4.10.1 Sinopharm Zhonglian Pharmaceutical Company Information
  57. 4.10.2 Sinopharm Zhonglian Pharmaceutical Business Overview
  58. 4.10.3 Sinopharm Zhonglian Pharmaceutical Steroidal MRAs Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Sinopharm Zhonglian Pharmaceutical Steroidal MRAs Product Portfolio
  60. 4.10.5 Sinopharm Zhonglian Pharmaceutical Recent Developments
  61. 4.11 Zydus
  62. 4.11.1 Zydus Company Information
  63. 4.11.2 Zydus Business Overview
  64. 4.11.3 Zydus Steroidal MRAs Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Zydus Steroidal MRAs Product Portfolio
  66. 4.11.5 Zydus Recent Developments
  67. 4.12 Viatris Pharmaceuticals
  68. 4.12.1 Viatris Pharmaceuticals Company Information
  69. 4.12.2 Viatris Pharmaceuticals Business Overview
  70. 4.12.3 Viatris Pharmaceuticals Steroidal MRAs Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Viatris Pharmaceuticals Steroidal MRAs Product Portfolio
  72. 4.12.5 Viatris Pharmaceuticals Recent Developments
  73. 4.13 Sun Pharmaceuticals
  74. 4.13.1 Sun Pharmaceuticals Company Information
  75. 4.13.2 Sun Pharmaceuticals Business Overview
  76. 4.13.3 Sun Pharmaceuticals Steroidal MRAs Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Sun Pharmaceuticals Steroidal MRAs Product Portfolio
  78. 4.13.5 Sun Pharmaceuticals Recent Developments
  79. 4.14 Sandoz
  80. 4.14.1 Sandoz Company Information
  81. 4.14.2 Sandoz Business Overview
  82. 4.14.3 Sandoz Steroidal MRAs Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Sandoz Steroidal MRAs Product Portfolio
  84. 4.14.5 Sandoz Recent Developments
  85. 4.15 Pfizer
  86. 4.15.1 Pfizer Company Information
  87. 4.15.2 Pfizer Business Overview
  88. 4.15.3 Pfizer Steroidal MRAs Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Pfizer Steroidal MRAs Product Portfolio
  90. 4.15.5 Pfizer Recent Developments
  91. 4.16 Mylan
  92. 4.16.1 Mylan Company Information
  93. 4.16.2 Mylan Business Overview
  94. 4.16.3 Mylan Steroidal MRAs Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Mylan Steroidal MRAs Product Portfolio
  96. 4.16.5 Mylan Recent Developments
  97. 4.17 MSN
  98. 4.17.1 MSN Company Information
  99. 4.17.2 MSN Business Overview
  100. 4.17.3 MSN Steroidal MRAs Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 MSN Steroidal MRAs Product Portfolio
  102. 4.17.5 MSN Recent Developments
  103. 4.18 Kyorin Rimedio
  104. 4.18.1 Kyorin Rimedio Company Information
  105. 4.18.2 Kyorin Rimedio Business Overview
  106. 4.18.3 Kyorin Rimedio Steroidal MRAs Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Kyorin Rimedio Steroidal MRAs Product Portfolio
  108. 4.18.5 Kyorin Rimedio Recent Developments
  109. 4.19 Camber Pharmaceuticals
  110. 4.19.1 Camber Pharmaceuticals Company Information
  111. 4.19.2 Camber Pharmaceuticals Business Overview
  112. 4.19.3 Camber Pharmaceuticals Steroidal MRAs Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Camber Pharmaceuticals Steroidal MRAs Product Portfolio
  114. 4.19.5 Camber Pharmaceuticals Recent Developments
  115. 4.20 Amneal Pharmaceuticals
  116. 4.20.1 Amneal Pharmaceuticals Company Information
  117. 4.20.2 Amneal Pharmaceuticals Business Overview
  118. 4.20.3 Amneal Pharmaceuticals Steroidal MRAs Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Amneal Pharmaceuticals Steroidal MRAs Product Portfolio
  120. 4.20.5 Amneal Pharmaceuticals Recent Developments
  121. 4.21 Actavis Elizabeth
  122. 4.21.1 Actavis Elizabeth Company Information
  123. 4.21.2 Actavis Elizabeth Business Overview
  124. 4.21.3 Actavis Elizabeth Steroidal MRAs Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Actavis Elizabeth Steroidal MRAs Product Portfolio
  126. 4.21.5 Actavis Elizabeth Recent Developments
  127. 4.22 Accord Healthcare
  128. 4.22.1 Accord Healthcare Company Information
  129. 4.22.2 Accord Healthcare Business Overview
  130. 4.22.3 Accord Healthcare Steroidal MRAs Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Accord Healthcare Steroidal MRAs Product Portfolio
  132. 4.22.5 Accord Healthcare Recent Developments
5 Global Steroidal MRAs Market Scenario by Region
  1. 5.1 Global Steroidal MRAs Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Steroidal MRAs Sales by Region: 2021-2032
  3. 5.2.1 Global Steroidal MRAs Sales by Region: 2021-2026
  4. 5.2.2 Global Steroidal MRAs Sales by Region: 2027-2032
  5. 5.3 Global Steroidal MRAs Revenue by Region: 2021-2032
  6. 5.3.1 Global Steroidal MRAs Revenue by Region: 2021-2026
  7. 5.3.2 Global Steroidal MRAs Revenue by Region: 2027-2032
  8. 5.4 North America Steroidal MRAs Market Facts & Figures by Country
  9. 5.4.1 North America Steroidal MRAs Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Steroidal MRAs Sales by Country (2021-2032)
  11. 5.4.3 North America Steroidal MRAs Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Steroidal MRAs Market Facts & Figures by Country
  16. 5.5.1 Europe Steroidal MRAs Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Steroidal MRAs Sales by Country (2021-2032)
  18. 5.5.3 Europe Steroidal MRAs Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Steroidal MRAs Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Steroidal MRAs Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Steroidal MRAs Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Steroidal MRAs Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Steroidal MRAs Market Facts & Figures by Country
  41. 5.7.1 South America Steroidal MRAs Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Steroidal MRAs Sales by Country (2021-2032)
  43. 5.7.3 South America Steroidal MRAs Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Steroidal MRAs Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Steroidal MRAs Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Steroidal MRAs Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Steroidal MRAs Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Steroidal MRAs Sales by Type (2021-2032)
  2. 6.1.1 Global Steroidal MRAs Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Steroidal MRAs Sales Market Share by Type (2021-2032)
  4. 6.2 Global Steroidal MRAs Revenue by Type (2021-2032)
  5. 6.2.1 Global Steroidal MRAs Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Steroidal MRAs Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Steroidal MRAs Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Steroidal MRAs Sales by Application (2021-2032)
  2. 7.1.1 Global Steroidal MRAs Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Steroidal MRAs Sales Market Share by Application (2021-2032)
  4. 7.2 Global Steroidal MRAs Revenue by Application (2021-2032)
  5. 7.2.1 Global Steroidal MRAs Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Steroidal MRAs Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Steroidal MRAs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Steroidal MRAs Value Chain Analysis
  2. 8.1.1 Steroidal MRAs Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Steroidal MRAs Production Mode & Process
  5. 8.2 Steroidal MRAs Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Steroidal MRAs Distributors
  8. 8.2.3 Steroidal MRAs Customers
9 Global Steroidal MRAs Analyzing Market Dynamics
  1. 9.1 Steroidal MRAs Industry Trends
  2. 9.2 Steroidal MRAs Industry Drivers
  3. 9.3 Steroidal MRAs Industry Opportunities and Challenges
  4. 9.4 Steroidal MRAs Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst